In addition to defective m6A modification of mutant EPRS1 mRNA in patient-derived LCLs, defective m6A modification was observed in mutation-bearing reporters in embryonic kidney-derived HEK293T cells and glioma-derived U87-MG cells. The gene discussed is EPRS1; the disease is central nervous system cancer.